Product Description
Mechanisms of Action: COX2 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Korea | Lebanon | Russia
Approved Indications: None
Known Adverse Events: None
Company: CrystalGenomics, Inc.
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Osteoarthritis, Hip|Osteoarthritis, Knee
Phase 2: Osteoarthritis, Knee|Osteoarthritis, Hip|Osteoarthritis
Phase 1: Healthy Volunteers|Hypertension|Osteoarthritis|Oncology Unspecified
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT05370716 |
CG100651-1-01 | P1 |
Completed |
Healthy Volunteers |
2020-04-30 |
2022-06-01 |
Primary Endpoints|Treatments |
|
NCT03774355 |
CG100649-1-07 | P1 |
Completed |
Healthy Volunteers |
2019-05-03 |
50% |
2019-09-29 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
NCT03775629 |
CG100650-1-01 | P1 |
Completed |
Healthy Volunteers |
2019-04-04 |
12% |
2022-05-12 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
NCT00780325 |
CA-I, CA-II | P1 |
Terminated |
Osteoarthritis|Hypertension |
2013-07-01 |
2019-03-18 |
||
NCT01154790 |
CG100649-1-04 | P1 |
Completed |
Healthy Volunteers |
2011-01-01 |
2019-03-19 |
Treatments |
|
NCT01154764 |
CG100649-1-03 | P1 |
Completed |
Healthy Volunteers|Oncology Unspecified |
2010-03-01 |
2024-01-04 |
Primary Endpoints |
|
NCT01341405 |
CG100649-2-02 | P2 |
Completed |
Osteoarthritis |
2011-12-01 |
2023-02-10 |
Primary Endpoints|Treatments |
|
2007-001197-93 |
2007-001197-93 | P2 |
Completed |
Osteoarthritis, Hip|Osteoarthritis, Knee |
2008-09-04 |
2022-03-12 |
Treatments |
|
NCT00530452 |
CG100649-2-01 | P2 |
Unknown status |
Osteoarthritis, Knee|Osteoarthritis, Hip |
2008-09-01 |
2019-03-21 |
Treatments |
|
NCT01765296 |
CG100649-3-01 | P3 |
Completed |
Osteoarthritis, Knee|Osteoarthritis, Hip |
2013-12-01 |
2023-02-16 |
Patient Enrollment|Primary Endpoints|Study Completion Date|Treatments|Trial Status |